Drug Trial Radar · NCT05911763
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jun 30, 2023
Primary completion
Jun 6, 2028
Study completion Sep 17, 2030
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jun 22, 2023
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, observational, multi-center longitudinal cohort study to describe the real-world effectiveness, safety and treatment usage of efanesoctocog alfa in patients with hemophilia A treated per standard of care in the US and Japan. Patients will be enrolled in the study after the introduction of efanesoctocog alfa in the hemophilia treatment landscape in each study country. Decision to initiate treatment with commercially available efanesoctocog alfa will be made by the treating physician independently from the decision to include patients in the study. No study medication is provided. The data related to efanesoctocog alfa effectiveness, safety and usage will be collected prospectively during routine visits (expected annual/semi-annual visits) for up to 5 years following enrollment /treatment initiation.
Conditions
- Hemophilia A
Interventions
Efanesoctocog Alfa BIVV001Drug
Given per investigator's discretion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Annualized joint bleeding rate (AjBR) for treated bleedsTime frame: Up to 5 years
- Change from baseline in Annualized joint bleeding rate (AjBR) for all (treated and untreated) bleedsTime frame: Up to 5 years
- Number of Target joint development, resolution and/or recurrenceTime frame: Up to 5 years
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Banner MD Anderson Cancer Center- Site Number : 8400008
Gilbert, Arizona
Loma Linda University- Site Number : 8400015
Loma Linda, California
Orthopedic Institute for Children- Site Number : 8400004
Los Angeles, California
The Center for Inherited Blood Disorders- Site Number : 8400001
Orange, California
University of Colorado Hemophilia and Thrombosis Center- Site Number : 8400019
Aurora, Colorado
William A. Shands Hospital at the University of Florida- Site Number : 8400032
Gainesville, Florida
Johns Hopkins All Childrens Hospital - Outpatient Care Center - PIN- Site Number : 8400025
St. Petersburg, Florida
Rush University Medical Center -1725 W Harrison St- Site Number : 8400014
Chicago, Illinois
The Bleeding and Clotting Disorders Institute- Site Number : 8400005
Peoria, Illinois
Indiana Hemophilia and Thrombosis Center- Site Number : 8400013
Indianapolis, Indiana
University Of Iowa Hospitals And Clinics- Site Number : 8400026
Iowa City, Iowa
~Massachusetts General Hospital- Site Number : 8400017
Boston, Massachusetts
Dana Farber and Boston Children's Hospital- Site Number : 8400031
Boston, Massachusetts
University of Michigan Hospital - 1500 E Medical Center Dr- Site Number : 8400023
Ann Arbor, Michigan
M Health Fairview- Masonic Cancer Clinic - Clinics- Site Number : 8400010
Minneapolis, Minnesota
Mayo Clinic - PPDS- Site Number : 8400035
Rochester, Minnesota
Mississippi Center For Advanced Medicine - 7731 Old Canton Rd- Site Number : 8400016
Madison, Mississippi
University of Nebraska Medical Center - 985400 Nebraska Medical Center- Site Number : 8400009
Omaha, Nebraska
Children's Specialty Center - Las Vegas- Site Number : 8400007
Las Vegas, Nevada
Weill Cornell Medicine-New York Presbyterian Hospital- Site Number : 8400021
New York, New York
Cincinnati Children's Hospital Medical Center - PIN- Site Number : 8400006
Cincinnati, Ohio
Hemophilia Center of Western Pennsylvania- Site Number : 8400012
Pittsburgh, Pennsylvania
Vanderbilt University Medical Center- Site Number : 8400003
Nashville, Tennessee
University of Texas Southwestern Medical Center-2001 Inwood Rd- Site Number : 8400020
Dallas, Texas
University of Texas Southwestern Medical Center- Site Number : 8400011
Dallas, Texas
Gulf States Hemophilia and Thrombophilia Center- Site Number : 8400029
Houston, Texas
Washington Institute for Coagulation- Site Number : 8400022
Seattle, Washington
Blood Center of Wisconnsin- Site Number : 8400027
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.